Can systemic corticosteroids such as prednisone cause hypomagnesemia?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 18, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Can Corticosteroids Cause Hypomagnesemia?

Yes, systemic corticosteroids including prednisone can cause hypomagnesemia, particularly with prolonged use exceeding 24 months or when combined with diuretics, though the effect is less pronounced than with other medications like aminoglycosides or cisplatin. 1

Evidence for Corticosteroid-Induced Hypomagnesemia

Direct Clinical Evidence

A study in 95 patients with severe chronic obstructive lung disease demonstrated a significant negative correlation between serum magnesium levels and duration of oral steroid therapy. Patients receiving oral corticosteroids for less than 24 months had serum magnesium levels of 1.64 ± 0.02 mEq/L, while those on therapy for greater than 24 months had significantly lower levels of 1.52 ± 0.06 mEq/L (p < 0.005). 1 This represents a clinically meaningful decline with prolonged exposure.

Mechanism and Clinical Significance

While corticosteroids are not classified among the medications causing "significant" hypomagnesemia (unlike cisplatin, amphotericin B, or cyclosporine), they fall into a category where monitoring becomes important with prolonged use or when combined with other risk factors. 2 The mechanism likely involves renal magnesium wasting, though this is less well-characterized than for other drug classes. 3

Risk Stratification and Monitoring Recommendations

High-Risk Scenarios Requiring Magnesium Monitoring

  • Duration of therapy: Oral corticosteroids for >24 months 1
  • Concurrent diuretic use: The combination of corticosteroids and diuretics significantly increases hypomagnesemia risk, as diuretics independently lower serum magnesium (1.59 ± 0.06 mEq/L vs. 1.71 mEq/L without diuretics, p < 0.001) 1
  • Presence of clinical manifestations: Neuromuscular symptoms (muscle cramps, tremor, tetany), cardiac arrhythmias, or refractory hypokalemia/hypocalcemia 4
  • Multiple concurrent medications: When corticosteroids are combined with other potentially hypomagnesemic drugs (aminoglycosides, proton pump inhibitors, calcineurin inhibitors) 2, 3

When to Check Magnesium Levels

Routine monitoring is warranted in patients on chronic corticosteroid therapy (>6 months) who have:

  • Concurrent diuretic therapy 1
  • Persistent hypokalemia or hypocalcemia despite replacement 2
  • Unexplained cardiac arrhythmias 4
  • Neuromuscular symptoms suggestive of electrolyte disturbance 4

Management Approach

For Asymptomatic Patients on Chronic Steroids

Monitor serum magnesium every 3-6 months if on therapy >24 months or if concurrent diuretics are used. 1 No preventive magnesium supplementation is required in the absence of documented hypomagnesemia. 2

For Symptomatic or Documented Hypomagnesemia

Treatment should be initiated when:

  • Serum magnesium <1.45 mEq/L (lower limit of normal) 1
  • Clinical manifestations are present regardless of serum level 4
  • Refractory hypokalemia or hypocalcemia exists 2

Replacement strategies:

  • Oral magnesium supplementation is preferred for chronic, mild-to-moderate deficiency (more effective at slowly replacing total body stores) 5
  • Intravenous magnesium is reserved for severe, life-threatening hypomagnesemia or when oral route is not tolerated 5

Important Clinical Caveats

Serum magnesium is a poor proxy for total body stores but correlates with symptom development. 5 Patients may have significant total body magnesium depletion with normal serum levels, particularly in critical illness. 4

The hypomagnesemic effect of corticosteroids is duration-dependent and dose-related. Short courses (7-20 days) used for acute conditions like asthma exacerbations 6 or inflammatory bowel disease flares 6 are unlikely to cause clinically significant hypomagnesemia. The risk becomes relevant with chronic therapy exceeding several months. 1

Corticosteroids cause multiple electrolyte disturbances beyond magnesium, including hypokalemia (particularly with hydrocortisone due to mineralocorticoid effects) 6, hyperglycemia, and sodium retention. 6 Comprehensive electrolyte monitoring is prudent in patients on prolonged therapy.

Do not overlook other causes of hypomagnesemia in patients on corticosteroids, as gastrointestinal losses, renal disease, and other medications are often more significant contributors. 3, 4

References

Research

An overview of diagnosis and management of drug-induced hypomagnesemia.

Pharmacology research & perspectives, 2021

Research

Hypomagnesemia in critically ill patients.

Journal of intensive care, 2018

Research

Acquired Disorders of Hypomagnesemia.

Mayo Clinic proceedings, 2023

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Related Questions

What symptoms can hypomagnesemia (low magnesium levels) of 0.3 mg/dL cause?
How do patients with hypomagnesemia present and who should be tested for magnesium levels?
What is the likely cause and appropriate management for a 41-year-old man with audible bowel sounds, serum magnesium 0.68 mmol/L (hypomagnesemia) and hemoglobin 12.5 g/dL (mild anemia)?
Can hypomagnesemia cause fatigue?
What is the treatment for hypomagnesemia (low magnesium levels)?
How is the brachial plexus divided?
A diabetic patient with admission hyperglycemia treated with insulin had a brief 2–3‑minute syncopal episode while glucose was 164 mg/dL; what are the differential diagnoses and how should it be managed?
How should I decide on revascularisation for a patient with coronary artery disease based on acute coronary syndrome status, symptom burden, objective evidence of myocardial ischemia, coronary anatomy, and procedural risk?
In an adult with end‑stage liver disease and portopulmonary hypertension (mean pulmonary artery pressure ≥35 mmHg, pulmonary vascular resistance >3 Wood units, right‑ventricular strain), what intra‑operative considerations are required for liver transplantation?
Can prolonged supine positioning cause increased daytime urinary frequency (recumbent diuresis) in a patient without heart failure, edema, renal disease, diabetes mellitus, or diabetes insipidus and with normal laboratory values?
What prophylactic anti‑seizure medication is recommended for a 2‑year‑old child with an open, non‑depressed frontal bone fracture?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.